p63 Promotes Cell Survival through Fatty Acid Synthase (Publication with Expression of Concern. See vol. 14, 2019)

被引:26
|
作者
Sabbisetti, Venkata
Di Napoli, Arianna
Seeley, Apryle
Amato, Angela M.
O'Regan, Esther
Ghebremichael, Musie
Loda, Massimo
Signoretti, Sabina
机构
[1] Department of Pathology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA
[2] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
[3] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
[4] St. James's Hospital, Dublin
来源
PLOS ONE | 2009年 / 4卷 / 06期
关键词
PROSTATE-CANCER; PHARMACOLOGICAL INHIBITION; INDUCED APOPTOSIS; DOWN-REGULATION; DIRECT TARGET; P53; HOMOLOG; EXPRESSION; GENE; ACTIVATION; OVEREXPRESSION;
D O I
10.1371/journal.pone.0005877
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
There is increasing evidence that p63, and specifically Delta Np63, plays a central role in both development and tumorigenesis by promoting epithelial cell survival. However, few studies have addressed the molecular mechanisms through which such important function is exerted. Fatty acid synthase (FASN), a key enzyme that synthesizes long-chain fatty acids and is involved in both embryogenesis and cancer, has been recently proposed as a direct target of p53 family members, including p63 and p73. Here we show that knockdown of either total or Delta N-specific p63 isoforms in squamous cell carcinoma (SCC9) or immortalized prostate epithelial (iPrEC) cells caused a decrease in cell viability by inducing apoptosis without affecting the cell cycle. p63 silencing significantly reduced both the expression and the activity of FASN. Importantly, stable overexpression of either FASN or myristoylated AKT (myr-AKT) was able to partially rescue cells from cell death induced by p63 silencing. FASN induced AKT phosphorylation and a significant reduction in cell viability was observed when FASN-overexpressing SCC9 cells were treated with an AKT inhibitor after p63 knockdown, indicating that AKT plays a major role in FASN-mediated survival. Activated AKT did not cause any alteration in the FASN protein levels but induced its activity, suggesting that the rescue from apoptosis documented in the p63-silenced cells expressing myr-AKT cells may be partially mediated by FASN. Finally, we demonstrated that p63 and FASN expression are positively associated in clinical squamous cell carcinoma samples as well as in the developing prostate. Taken together, our findings demonstrate that FASN is a functionally relevant target of p63 and is required for mediating its pro-survival effects.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] p63 Promotes Cell Survival through Fatty Acid Synthase (Expression of Concern of Vol 4, 2009)
    Sabbisetti, V
    Di Napoli, A.
    Seeley, A.
    Amato, A. M.
    O'Regan, E.
    Ghebremichael, M.
    PLOS ONE, 2019, 14 (07):
  • [2] Evaluating the strength of genetic results: Risks and responsibilities (Publication with Expression of Concern. See vol. 15, 2019) (Publication with Expression of Concern. See vol. 15, 2019)
    Barsh, Gregory S.
    Cooper, Gregory M.
    Copenhaver, Gregory P.
    Sirugo, Giorgio
    Tang, Hua
    Williams, Scott M.
    PLOS GENETICS, 2019, 15 (10):
  • [3] Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors (Publication with Expression of Concern. See vol. 14, 2019) (Publication with Expression of Concern. See vol. 14, 2019)
    Morgillo, Floriana
    Martinelli, Erika
    Troiani, Teresa
    Orditura, Michele
    De Vita, Ferdinando
    Ciardiello, Fortunato
    PLOS ONE, 2011, 6 (12):
  • [4] Microenvironment Promotes Tumor Cell Reprogramming in Human Breast Cancer Cell Lines (Publication with Expression of Concern. See vol. 14, 2019)
    D'Anselmi, Fabrizio
    Masiello, Maria Grazia
    Cucina, Alessandra
    Proietti, Sara
    Dinicola, Simona
    Pasqualato, Alessia
    Ricci, Giulia
    Dobrowolny, Gabriella
    Catizone, Angela
    Palombo, Alessandro
    Bizzarri, Mariano
    PLOS ONE, 2013, 8 (12):
  • [5] RETRACTED: Human Cardiac Stem Cell Differentiation Is Regulated by a Mircrine Mechanism (Publication with Expression of Concern. See vol. 139, 2019) (Publication with Expression of Concern. See vol. 139, 2019) (Retracted article. See vol. 139, 2019)
    Hosoda, Toru
    Zheng, Hanqiao
    Cabral-da-Silva, Mauricio
    Sanada, Fumihiro
    Ide-Iwata, Noriko
    Ogorek, Barbara
    Ferreira-Martins, Joao
    Arranto, Christian
    D'Amario, Domenico
    del Monte, Federica
    Urbanek, Konrad
    D'Alessandro, David A.
    Michler, Robert E.
    Anversa, Piero
    Rota, Marcello
    Kajstura, Jan
    Leri, Annarosa
    CIRCULATION, 2011, 123 (12) : 1287 - U100
  • [6] Estimation of the laser cutting operating cost by support vector regression methodology (Publication with Expression of Concern. See vol. 125, 2019) (Publication with Expression of Concern. See vol. 125, 2019)
    Jovic, Srdan
    Radovic, Aleksandar
    Sarkocevic, Zivce
    Petkovic, Dalibor
    Alizamir, Meysam
    APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING, 2016, 122 (09):
  • [7] Does ovary need D-chiro-inositol? (Publication with Expression of Concern. See vol. 11, 2018) (Publication with Expression of Concern. See vol. 11, 2018) (Publication with Expression of Concern. See vol. 11, 2018)
    Isabella, Rosalbino
    Raffone, Emanuela
    JOURNAL OF OVARIAN RESEARCH, 2012, 5
  • [8] Production Conditions Affect the In Vitro Anti-Tumoral Effects of a High Concentration Multi-Strain Probiotic Preparation (Publication with Expression of Concern. See vol. 14, 2019) (Publication with Expression of Concern. See vol. 14, 2019)
    Cinque, Benedetta
    La Torre, Cristina
    Lombardi, Francesca
    Palumbo, Paola
    Van der Rest, Michel
    Cifone, Maria Grazia
    PLOS ONE, 2016, 11 (09):
  • [9] RETRACTED: Increased bone resorption during the first year after stroke (Publication with Expression of Concern. See vol. 50, 2019) (Publication with Expression of Concern. See vol. 50, 2019) (Retracted article. See vol. 50, 2019)
    Sato, Y
    Kuno, H
    Kaji, M
    Ohshima, Y
    Asoh, T
    Oizumi, K
    STROKE, 1998, 29 (07) : 1373 - 1377
  • [10] Sacubitril/valsartan in PARADIGM-HF (Publication with Expression of Concern. See vol. 7, pg. 250, 2019) (Publication with Expression of Concern. See vol. 7, pg. 250, 2019)
    Vodovar, Nicolas
    Nougue, Helene
    Launay, Jean-Marie
    Solal, Alain Cohen
    Logeart, Damien
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (07): : 495 - 496